A Phase II Trial of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2018
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Adenoid cystic carcinoma
- Focus Therapeutic Use
- 23 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 25 Apr 2017 Status changed from not yet recruiting to recruiting.
- 24 Mar 2017 New trial record